EFFECTS OF DENOSUMAB ON PAIN AND ANALGESIC USE IN GIANT CELL TUMOUR OF BONE: RESULTS FROM A PHASE 2 STUDY

被引：0
|
作者：
Broto, J. [1 ]
Cleeland, C. [2 ]
Skubitz, K. [3 ]
Staddon, A. [4 ]
Blum, R. [5 ]
Dominkus, M. [6 ]
Engellau, J. [7 ]
Ganjoo, K. [8 ]
Atchison, C. [9 ]
Qian, Y. [9 ]
Jacobs, I. [9 ]
机构：
[1] Hosp Univ Son Espases, Palma De Mallorca, Spain
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA
[4] Univ Penn, Sch Med, Philadelphia, PA 19104 USA
[5] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA
[6] Med Univ Wien, Vienna, Austria
[7] Skane Univ Hosp, Lund, Sweden
[8] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：52 / 52
页数：1
相关论文
共 50 条
  • [1] Effects of denosumab on pain and analgesic use in giant cell tumor of bone: Interim results from a phase II study
    Martin-Broto, Javier
    Cleeland, Charles S.
    Glare, Paul A.
    Engellau, Jacob
    Skubitz, Keith M.
    Blum, Ronald H.
    Ganjoo, Kristin N.
    Staddon, Arthur
    Dominkus, Martin
    Feng, Amy
    Qian, Yi
    Braun, Ada
    Jacobs, Ira
    Chung, Karen
    Atchison, Carolyn
    ACTA ONCOLOGICA, 2014, 53 (09) : 1173 - 1179
  • [2] Effects of denosumab on pain reduction in giant cell tumor of bone (GCTB): Interim phase II study results.
    Cleeland, C. S.
    Staddon, A. P.
    Schuetze, S.
    Powell, A.
    Pousa, A. Lopez
    Cioffi, A.
    Kroep, J. R.
    Stacchiotti, S.
    Chung, K.
    Atchison, C.
    Qian, Y.
    Zhao, Y.
    Jacobs, I. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [3] The current standing on the use of denosumab in giant cell tumour of the bone
    Singh, Vivek Ajit
    Puri, Ajay
    JOURNAL OF ORTHOPAEDIC SURGERY, 2020, 28 (03)
  • [4] Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study
    Thomas, David
    Henshaw, Robert
    Skubitz, Keith
    Chawla, Sant
    Staddon, Arthur
    Blay, Jean-Yves
    Roudier, Martine
    Smith, Judy
    Ye, Zhishen
    Sohn, Winnie
    Dansey, Roger
    Jun, Susie
    LANCET ONCOLOGY, 2010, 11 (03): : 275 - 280
  • [5] Giant cell tumour of bone in the denosumab era
    van der Heijden, Lizz
    Dijkstra, P. D. Sander
    Blay, Jean-Yves
    Gelderblom, Hans
    EUROPEAN JOURNAL OF CANCER, 2017, 77 : 75 - 83
  • [6] Denosumab treatment of giant cell tumour of bone
    Balke, Maurice
    LANCET ONCOLOGY, 2013, 14 (09): : 801 - 802
  • [7] Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study
    Chawla, Sant
    Blay, Jean-Yves
    Rutkowski, Piotr
    Le Cesne, Axel
    Reichardt, Peter
    Gelderblom, Hans
    Grimer, Robert J.
    Choy, Edwin
    Skubitz, Keith
    Seeger, Leanne
    Schuetze, Scott M.
    Henshaw, Robert
    Dai, Tian
    Jandial, Danielle
    Palmerini, Emanuela
    LANCET ONCOLOGY, 2019, 20 (12): : 1719 - 1729
  • [8] Denosumab in the treatment of giant cell tumor of bone: preliminary results from an open-label phase 2 study
    Thomas, D.
    Chawla, S.
    Skubitz, K.
    Staddon, A.
    Henshaw, R.
    Smith, J.
    Ye, Z.
    Sohn, W.
    Jun, S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2008, 25 : 66 - 66
  • [9] Denosumab for giant cell tumour of bone: success and limitations
    Healey, John H.
    LANCET ONCOLOGY, 2019, 20 (12): : 1627 - 1628
  • [10] Giant cell tumour of the bone under treatment with Denosumab
    Gama, J.
    Madeira, J.
    Oliveira, R.
    Faria, C.
    Almeida, V.
    Ramalhosa, F.
    Sepodes, B.
    Fontinha, G.
    Courelas, C.
    Alves, A.
    Cipriano, M. A.
    VIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S339 - S339
12345